Search

Patrick T. Lewis

Examiner (ID: 16456, Phone: (571)272-0655 , Office: P/1672 )

Most Active Art Unit
1623
Art Unit(s)
1623, 1621, 1693, 1691, 1672, 1673
Total Applications
1936
Issued Applications
1309
Pending Applications
238
Abandoned Applications
439

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18871146 [patent_doc_number] => 11858931 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-02 [patent_title] => Amino acid compounds with unbranched linkers and methods of use [patent_app_type] => utility [patent_app_number] => 17/679002 [patent_app_country] => US [patent_app_date] => 2022-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 2 [patent_no_of_words] => 32445 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679002 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/679002
Amino acid compounds with unbranched linkers and methods of use Feb 22, 2022 Issued
Array ( [id] => 20343127 [patent_doc_number] => 12466849 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-11 [patent_title] => Anti-viral and anti-tumoral compounds [patent_app_type] => utility [patent_app_number] => 17/583378 [patent_app_country] => US [patent_app_date] => 2022-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 76 [patent_figures_cnt] => 105 [patent_no_of_words] => 65301 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583378 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/583378
Anti-viral and anti-tumoral compounds Jan 24, 2022 Issued
Array ( [id] => 17790441 [patent_doc_number] => 20220249532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => COMBINATION THERAPY FOR HIV WITH ADENOSINE DERIVATIVE AND CAPSID INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/583815 [patent_app_country] => US [patent_app_date] => 2022-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27004 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -77 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583815 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/583815
Combination therapy for HIV with adenosine derivative and capsid inhibitors Jan 24, 2022 Issued
Array ( [id] => 19316882 [patent_doc_number] => 20240238422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => Hypoimmunogenic Biotherapeutics [patent_app_type] => utility [patent_app_number] => 18/036844 [patent_app_country] => US [patent_app_date] => 2022-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59567 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18036844 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/036844
Hypoimmunogenic Biotherapeutics Jan 9, 2022 Pending
Array ( [id] => 17546643 [patent_doc_number] => 20220117984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => METHODS OF USING HUMAN MILK OLIGOSACCHARIDES FOR IMPROVING AIRWAY RESPIRATORY HEALTH [patent_app_type] => utility [patent_app_number] => 17/562327 [patent_app_country] => US [patent_app_date] => 2021-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19049 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17562327 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/562327
Methods of using human milk oligosaccharides for improving airway respiratory health Dec 26, 2021 Issued
Array ( [id] => 17546643 [patent_doc_number] => 20220117984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => METHODS OF USING HUMAN MILK OLIGOSACCHARIDES FOR IMPROVING AIRWAY RESPIRATORY HEALTH [patent_app_type] => utility [patent_app_number] => 17/562327 [patent_app_country] => US [patent_app_date] => 2021-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19049 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17562327 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/562327
Methods of using human milk oligosaccharides for improving airway respiratory health Dec 26, 2021 Issued
Array ( [id] => 19096365 [patent_doc_number] => 20240115592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => PGC-1alpha EXPRESSION PROMOTING AGENT, MUSCLE-BUILDING AGENT AND MITOCHONDRIA ACTIVATING AGENT [patent_app_type] => utility [patent_app_number] => 18/257724 [patent_app_country] => US [patent_app_date] => 2021-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5761 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18257724 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/257724
PGC-1alpha EXPRESSION PROMOTING AGENT, MUSCLE-BUILDING AGENT AND MITOCHONDRIA ACTIVATING AGENT Dec 26, 2021 Pending
Array ( [id] => 18953583 [patent_doc_number] => 20240041910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => MUSCULAR ATROPHY INHIBITOR AND METHOD FOR INHIBITING MUSCULAR ATROPHY [patent_app_type] => utility [patent_app_number] => 18/258977 [patent_app_country] => US [patent_app_date] => 2021-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5451 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258977 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/258977
MUSCULAR ATROPHY INHIBITOR AND METHOD FOR INHIBITING MUSCULAR ATROPHY Dec 26, 2021 Pending
Array ( [id] => 19403611 [patent_doc_number] => 20240287122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => NOVEL GALACTOSIDE INHIBITOR OF GALECTINS [patent_app_type] => utility [patent_app_number] => 18/258656 [patent_app_country] => US [patent_app_date] => 2021-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27243 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258656 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/258656
NOVEL GALACTOSIDE INHIBITOR OF GALECTINS Dec 19, 2021 Pending
Array ( [id] => 19403611 [patent_doc_number] => 20240287122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => NOVEL GALACTOSIDE INHIBITOR OF GALECTINS [patent_app_type] => utility [patent_app_number] => 18/258656 [patent_app_country] => US [patent_app_date] => 2021-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27243 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258656 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/258656
NOVEL GALACTOSIDE INHIBITOR OF GALECTINS Dec 19, 2021 Pending
Array ( [id] => 19067161 [patent_doc_number] => 20240101587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => BIOMASS REMOVAL BY CENTRIFUGATION [patent_app_type] => utility [patent_app_number] => 18/257986 [patent_app_country] => US [patent_app_date] => 2021-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20794 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18257986 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/257986
BIOMASS REMOVAL BY CENTRIFUGATION Dec 16, 2021 Pending
Array ( [id] => 18707548 [patent_doc_number] => 20230330124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT AND PREVENTION OF A RED BLOOD CELL DISORDER [patent_app_type] => utility [patent_app_number] => 18/028080 [patent_app_country] => US [patent_app_date] => 2021-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16502 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 625 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18028080 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/028080
Nicotinamide mononucleotide derivatives and use thereof in the treatment and prevention of a red blood cell disorder Dec 16, 2021 Issued
Array ( [id] => 19067161 [patent_doc_number] => 20240101587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => BIOMASS REMOVAL BY CENTRIFUGATION [patent_app_type] => utility [patent_app_number] => 18/257986 [patent_app_country] => US [patent_app_date] => 2021-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20794 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18257986 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/257986
BIOMASS REMOVAL BY CENTRIFUGATION Dec 16, 2021 Pending
Array ( [id] => 20371267 [patent_doc_number] => 12478682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-25 [patent_title] => Nucleic acid conjugates and uses thereof [patent_app_type] => utility [patent_app_number] => 17/552750 [patent_app_country] => US [patent_app_date] => 2021-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 36041 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552750 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/552750
Nucleic acid conjugates and uses thereof Dec 15, 2021 Issued
Array ( [id] => 17635007 [patent_doc_number] => 11345720 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-31 [patent_title] => Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof [patent_app_type] => utility [patent_app_number] => 17/551592 [patent_app_country] => US [patent_app_date] => 2021-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 144078 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551592 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/551592
Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof Dec 14, 2021 Issued
Array ( [id] => 17460285 [patent_doc_number] => 20220073590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => Fusion Albumin Nanoparticle and Application Thereof [patent_app_type] => utility [patent_app_number] => 17/532182 [patent_app_country] => US [patent_app_date] => 2021-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4549 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532182 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/532182
Fusion albumin nanoparticle and application thereof Nov 21, 2021 Issued
Array ( [id] => 17627408 [patent_doc_number] => 20220162423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => Cellulose Ester Composition and Articles Made Therefrom [patent_app_type] => utility [patent_app_number] => 17/531336 [patent_app_country] => US [patent_app_date] => 2021-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6538 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17531336 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/531336
Cellulose ester composition and articles made therefrom Nov 18, 2021 Issued
Array ( [id] => 17546653 [patent_doc_number] => 20220117994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => METHOD OF PREVENTING OF SYSTEMIC-TO-PULMONARY-ARTERY SHUNT THROMBOSIS [patent_app_type] => utility [patent_app_number] => 17/513079 [patent_app_country] => US [patent_app_date] => 2021-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9763 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17513079 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/513079
METHOD OF PREVENTING OF SYSTEMIC-TO-PULMONARY-ARTERY SHUNT THROMBOSIS Oct 27, 2021 Abandoned
Array ( [id] => 18842633 [patent_doc_number] => 20230405037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 18/250674 [patent_app_country] => US [patent_app_date] => 2021-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9228 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250674 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/250674
PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME FOR TREATING CANCER Oct 26, 2021 Pending
Array ( [id] => 19464085 [patent_doc_number] => 20240317754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => METHODS AND MODIFIED NUCLEOSIDES FOR TREATING CORONAVIRUS INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/270009 [patent_app_country] => US [patent_app_date] => 2021-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17901 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270009 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/270009
METHODS AND MODIFIED NUCLEOSIDES FOR TREATING CORONAVIRUS INFECTIONS Sep 14, 2021 Pending
Menu